DAFNA Capital Management, LLC, a Los Angeles based SEC registered investment advisor, specializes in managing long/short portfolios of predominantly publicly traded biotechnology and medical device companies. Founded in 1999, for over 18 years we have funded the future of medicine and prudently managed the wealth entrusted with us by our investors. DAFNA Capital Management’s principal mission is capital preservation and strong annualized return over longer time periods with minimum risk. Investment returns are generated as a product of recognizing our responsibility to improve human health through the efficient allocation of capital to the most promising preventive, diagnostic, and therapeutic interventions.